重组凝血因子IX-白蛋白融合蛋白经静脉给药后在啮齿类动物中的组织分布
本研究在正常大鼠和血友病B小鼠静脉给予2000 IU/kg的rIX-FP后,于给药后72小时内多个时间点检测血浆和组织中的FIX抗原水平(ELISA或免疫组化)及FIX活性(仅小鼠,显色法)。结果显示rIX-FP分布至肝、肾、皮肤和膝等组织,峰值抗原水平在给药后1至7小时达到,组织抗原水平与活性读数良好相关。结论证实rIX-FP可分布至相关靶组织,且组织中rIX-FP保留功能活性。
要点
- rIX-FP经静脉给药后可分布至肝、肾、皮肤和膝等血管外组织。
- 大鼠组织中rIX-FP峰值抗原水平在给药后1至7小时达到。
- 血友病B小鼠中rIX-FP组织分布与大鼠相当,组织FIX抗原水平与活性读数良好相关。
核心结论
- 本研究结果证实了既往QWBA数据,显示rIX-FP可分布至相关靶组织。
- 研究显示组织中存在的rIX-FP保留其功能活性,从而可在潜在损伤部位促进其治疗活性。
研究设计与样本
- 研究在正常大鼠和FIX缺陷(血友病B)小鼠中静脉给予rIX-FP 2000 IU/kg,给药后至72小时特定时间点安乐死动物,采集血浆及基于既往QWBA结果选定的多种组织。
- 采用ELISA(两种动物)或免疫组化方法(仅小鼠)分析FIX抗原水平,并采用显色法分析FIX活性水平(仅小鼠)。
主要发现
- 在大鼠中,rIX-FP分布至所有分析的组织(即肝、肾、皮肤和膝)的血管外,峰值抗原水平在给药后1至7小时达到。
- 在血友病B小鼠中,rIX-FP组织分布与大鼠相当。
- FIX抗原水平与FIX活性读数良好相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Hemophilia B is caused by coagulation factor IX (FIX) deficiency. Recombinant fusion protein linking coagulation FIX with recombinant albumin (rIX-FP; Idelvion® ) is used for replacement therapy with an extended half-life. A previous quantitative whole-body autoradiography (QWBA) study investigating the biodistribution of rIX-FP indicated equal biodistribution, but more prolonged tissue retention compared with a marketed recombinant FIX product. OBJECTIVES: To complete and confirm the QWBA study data by directly measuring rIX-FP protein and activity levels in tissues following intravenous (i.v.) administration to normal rats and FIX-deficient (hemophilia B) mice. METHODS: After i.v. administration of rIX-FP at a dose of 2000 IU/kg, animals were euthanized at specific time points up to 72 hours postdosing. Subsequently, plasma and various tissues, which were selected based on the previous QWBA results, were harvested and analyzed for FIX antigen levels using an ELISA (both species) or an immunohistochemistry method (mice only), as well as for FIX activity levels (mice only) using a chromogenic assay. RESULTS: In rats, rIX-FP distributed extravascularly into all tissues analyzed (ie, liver, kidney, skin and knee) with peak antigen levels reached between 1 and 7 hours postdosing. In hemophilia B mice, rIX-FP tissue distribution was comparable to rats. FIX antigen levels correlated well with FIX activity readouts. CONCLUSIONS: Our results confirm QWBA data showing that rIX-FP distributes into relevant target tissues. Importantly, it was demonstrated that rIX-FP available in tissues retains its functional activity and can thus facilitate its therapeutic activity at sites of potential injury.
引用
- Herrmann S, Doerr B, May F, et al. Tissue distribution of rIX-FP after intravenous application to rodents. J Thromb Haemost. 2020. PMID: 32810892. doi:10.1111/jth.15069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。